Table 1. 20 downregulated pathways found by a GSEA between A549 cell with and without Rig-G overexpression.
KEGG Pathway | P value | Enrichment |
---|---|---|
Pathways in cancer | 0.017 | Down |
Wnt signaling pathway | 0.006 | Down |
NF-κB signaling pathway | 0.001 | Down |
Axon guidance | 0.023 | Down |
Renal cell carcinoma | 0 | Down |
Cell cycle | 0.001 | Down |
Chemokine signaling pathway | 0 | Down |
Cytokine-cytokine receptor interaction | 0 | Down |
Arginine and proline metabolism | 0.007 | Down |
Retinol metabolism | 0.002 | Down |
Complement and coagulation cascades | 0.003 | Down |
VEGF signaling pathway | 0.002 | Down |
Terpenoid backbone biosynthesis | 0 | Down |
Glycerophospholipid metabolism | 0.031 | Down |
Aminoacyl-tRNA biosynthesis | 0.018 | Down |
Tryptophan metabolism | 0.001 | Down |
Cell adhesion molecules (CAMs) | 0.0004 | Down |
DNA replication | 0.002 | Down |
Endocytosis | 0.004 | Down |
Nucleotide excision repair | 0 | Down |
The enrichment is relative to the enrichment specifier and relative to the A549 without Rig-G overexpression.